Dry Eye Rescue Is Offering Friends Of MDA A 20% Discount On All Products To Help With Your Eye Conditions

Click Here To Save Now

Resources

Feb 17, 2025

COPHy The 16th Annual Congress on Controversies in Ophthalmolgy

COPHy VOD Unlock unparalleled access to the world of ophthalmology! ComtecMed VOD platform is your gateway to the exclusive annual World Congress on Controversies in Ophthalmology (COPHy). With lectures and debates…

COPHy The 16th Annual Congress on Controversies in Ophthalmolgy

Feb 17, 2025

MIND diet ranked no. 1 for brain health

Published February 3, 2025 | Originally published on Newswise: Health Food A diet created by researchers at Rush is ranked among the top diets for 2025 by U.S. News & World Report. Best Diets…

MIND diet ranked no. 1 for brain health

Feb 14, 2025

FDA approves amended label for Izervay for geographic atrophy

February 13, 2025 By Emily Kaiser Maharjan, Assistant Managing Editor The approval follows a refiling after the FDA issued a Complete Response Letter regarding language on the amended label. The FDA…

FDA approves amended label for Izervay for geographic atrophy

Feb 11, 2025

Regeneron reveals positive results from multiple trials evaluating Eylea HD (aflibercept) injection 8 mg

February 10, 2025, By Martin David Harp Results were published from the phase 3 QUASAR trial and the extension study of the phase 3 PULSAR trial. Regeneron Pharmaceuticals has announced results…

Regeneron reveals positive results from multiple trials evaluating Eylea HD (aflibercept) injection 8 mg

Feb 11, 2025

February is Low Vision Awareness Month

Did you know that?  Statistics show that low vision affects 2.2 billion people globally, and 12 million in the US, impacting their daily lives. Low Vision can result due to…

February is Low Vision Awareness Month

Feb 10, 2025

Federal Policy Announcements and Discussions about Funding Research

    Dear Macular Degeneration Association Friends, The recent federal policy announcements and discussions about funding research have raised questions from our donors about the potential impact on biomedical research.…

Federal Policy Announcements and Discussions about Funding Research

Feb 10, 2025

February is Macular Degeneration Awareness Month

Here is important information about macular degeneration, which is known as the number one cause of irreversible blindness and visual impairment in the older population. Age-related macular degeneration (AMD) is…

February is Macular Degeneration Awareness Month

Feb 4, 2025

Notal Vision publishes positive results from pivotal study of AI algorithm in home-based OCT system

    Author(s): Martin David Harp Key Takeaways The AI algorithm demonstrated strong repeatability and agreement with expert graders in segmenting hypo-reflective spaces in nAMD patients. The AI’s repeatability in…

Notal Vision publishes positive results from pivotal study of AI algorithm in home-based OCT system

Feb 4, 2025

February is Age-Related Macular Degeneration Month

            February is Age-Related Macular Degeneration (AMD) Awareness Month Did you know that there are three forms of age-related macular degeneration? Dry AMD is a…

February is Age-Related Macular Degeneration Month

Feb 4, 2025

Using Artificial Intelligence to Investigate the Real-world effect of Anti-complement Medications on Retinal Photoreceptor Survival in Patients with Geographic Atrophy

Using Artificial Intelligence to Investigate the Real-world effect of Anti-complement Medications on Retinal Photoreceptor Survival in Patients with Geographic Atrophy- Research project funded by the Macular Degeneration Association Principal Investigator: …

Using Artificial Intelligence to Investigate the Real-world effect of Anti-complement Medications on Retinal Photoreceptor Survival in Patients with Geographic Atrophy

Feb 3, 2025

Intracranial pressure levels may be a critical factor in glaucoma

Key takeaways: Glaucoma may be a result of two pressures: IOP and intracranial pressure. When one pressure is high and the other is low, it results in ganglion cell proptosis,…

Intracranial pressure levels may be a critical factor in glaucoma

Jan 31, 2025

Opening our eyes to the impact of preservatives

January 30, 2025 By Elyse Rayborn, OD, MBA, FAAO Chris Lievens, OD, MS, FAAO, FNAP Optometry Times JournalJanuary/February digital edition 2025 Preservatives may disrupt the ocular surface, contributing to poor adherence.…

Opening our eyes to the impact of preservatives

Jan 31, 2025

Are Blueberries Good for Diabetes?

Blueberries are packed with vitamins, antioxidants, and minerals that promote overall health. For people living with diabetes, blueberries may also help with glucose processing, weight loss, and insulin sensitivity. Blueberry…

Are Blueberries Good for Diabetes?

Jan 29, 2025

Stop drinking coffee wrong: Here’s the healthiest time for caffeine

By Elizabeth Pratt | Fact-checked by Davi Sherman | Published January 27, 2025 Industry Insights “It’s not just whether you drink coffee or how much you drink, but [also] the time of day when you drink coffee, that’s…

Stop drinking coffee wrong: Here’s the healthiest time for caffeine

Jan 24, 2025

Dispelling eye health myths seen on social media

By Dagny Zhu, MD The contents of this article are informational only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment recommendations. This editorial…

Dispelling eye health myths seen on social media

Jan 21, 2025

Living with Wet AMD – Tips for Maintaining Independence

  by: Jarred Long, OD – Low Vision Optometrist A diagnosis of wet age-related macular degeneration (AMD) can feel overwhelming, but it doesn’t have to mean giving up the activities…

Living with Wet AMD – Tips for Maintaining Independence

Jan 20, 2025

Soliddd Introduces its SolidddVision Smartglasses Technology at CES 2025

Patented virtual reality smartglasses are the first true vision correction for people living with vision loss due to macular degeneration Published on: 07 Jan 2025, 8:43 am LAS VEGAS and NEW YORK,…

Soliddd Introduces its SolidddVision Smartglasses Technology at CES 2025

Jan 9, 2025

One Small Step for Geographic Atrophy: Monitor Your Cholesterol and Blood Pressure Levels

Take Aways Blood Pressure Cholesterol Keeping track of these numbers could help slow the progression of age-related macular degeneration and delay vision loss if you already have geographic atrophy. Geographic…

One Small Step for Geographic Atrophy: Monitor Your Cholesterol and Blood Pressure Levels

Jan 1, 2025

Happy New Year 2025

  Happy New Year May this year bring, joy, peace, and hope.

Happy New Year 2025

Dec 24, 2024

Happy Holidays

  Happy Holidays from everyone at the Macular Degeneration Association. As the year ends, we thank you for your never-ending support. New research & treatments are transforming the landscape for…

Happy Holidays

Dec 23, 2024

First of its kind study lists health benefits of drinking more water each day

Published December 18, 2024 | Originally published on ScienceAlert Latest We all know that staying hydrated is good for human health – but a new study goes into more specific detail about all the various benefits…

First of its kind study lists health benefits of drinking more water each day

Dec 20, 2024

A look at geographic atrophy in 2024: The highs, lows of treatment trials

By: Kate Young-Fact checked by: Heather Biele In 2024, Healio covered several stories about trials investigating geographic atrophy biomarkers and treatment options. While one trial found that intravitreal pegcetacoplan showed…

A look at geographic atrophy in 2024: The highs, lows of treatment trials

Dec 17, 2024

The Macular Degeneration Association Welcomes New Medical Board Member

The Macular Degeneration Association (MDA) is proud to welcome Jessica Cameron, OD, FAAO as one of our distinguished Medical Board members. Dr. Cameron is a low vision specialist. She owns…

The Macular Degeneration Association Welcomes New Medical Board Member

Dec 17, 2024

Press Release – EYLEA HD Phase 3 Trial results (QUASAR trial)

  Eylea HD injection of 8 gm in the Phase 3 trial (QUASAR trial) is meeting the primary endpoints showing improved vision with extended dosing intervals in patients with macular…

Press Release – EYLEA HD Phase 3 Trial results (QUASAR trial)

Dec 16, 2024

Galimedix Therapeutics initiates phase 1 trial of oral GAL-101

Author(s): David Hutton Key Takeaways GAL-101 targets misfolded amyloid beta monomers, preventing toxic oligomer and protofibril formation, with potential applications in Alzheimer’s, dry AMD, and glaucoma. The Phase 1 trial…

Galimedix Therapeutics initiates phase 1 trial of oral GAL-101

Dec 12, 2024

Exclusive 20% Off on Your Eye Care Essentials!

  As part of our ongoing commitment to your eye health, we wanted to alert you about our partnership with DryEye Rescue, a trusted provider of specialized eye care products.…

Exclusive 20% Off on Your Eye Care Essentials!

Dec 10, 2024

‘Not all chocolate is created equal’: New data imply the dark variety lowers diabetes risk

By: Andrew (Drew) Rhoades Fact checked by: Gina Brockenbrough, MA  Key takeaways: Eating 5 ounces or more of chocolate a week lowered type 2 diabetes risk. Results showed no link…

‘Not all chocolate is created equal’: New data imply the dark variety lowers diabetes risk

Dec 10, 2024

ARCHER trial shows benefit of ANX007 on vision loss in geographic atrophy

By: Michela Cimberle Fact checked by Christine Klimanskis, ELS BARCELONA, Spain — In the phase 2 ARCHER trial, ANX007, a novel C1q inhibitor with neuroprotective properties, showed consistent protection against loss of…

ARCHER trial shows benefit of ANX007 on vision loss in geographic atrophy

Dec 9, 2024

Is Nutrition The Culprit? With Dr. Poteet

A new video discusses nutrition and its affects on our bodies and our eyes. Did you know your nutrition can impact your risk of disease? Dr. Julie Poteet is a…

Is Nutrition The Culprit? With Dr. Poteet

Dec 3, 2024

Sun Pharma announces positive Phase 4 data results in dry eye disease

Author(s): David Hutton Key Takeaways Cyclosporine ophthalmic solution 0.09% significantly improves dry eye disease symptoms in patients inadequately controlled on Restasis. The Phase 4 study showed sustained improvements in corneal…

Sun Pharma announces positive Phase 4 data results in dry eye disease

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.